Home> Products> pituitary gonadotropins

{ "products": [ { "_id": "694919f0de5d3e57a93413a8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "elagolix 150mg tablet", "description": "Eligolux 150 delivers 150mg of elagolix per tablet, formulated as an oral, once-daily option in convenient packs for ongoing therapy. As a non-peptide GnRH receptor antagonist, it selectively suppresses pituitary gonadotropins, reducing ovarian estrogen production without the flare effect of agonists. Ideal for patients with milder symptoms or those prioritizing bone health, this dose minimizes hypoestrogenic risks while targeting endometriotic pain.\n\nTake Eligolux 150 whole with water, with or without food, preferably at the same time daily. Storage requires a cool, dry environment below 30°C, away from children and moisture. Steris Healthcare ensures GMP-compliant manufacturing, making it accessible across India for endometriosis care.\n\nPrimary Uses and Indications\nEligolux 150 primarily treats moderate endometriosis-associated pain, including dysmenorrhea, chronic pelvic discomfort, and dyspareunia. Endometriosis impacts 10% of reproductive-age women, causing ectopic endometrial growth that triggers inflammation and scarring; elagolix 150mg curbs estrogen-driven progression.\n​\nPrescribed when NSAIDs or combined pills prove inadequate, it excels in non-severe cases, allowing prolonged use. Emerging evidence supports its role in heavy menstrual bleeding from fibroids, though primary approval focuses on pain relief. Start therapy within the first week of menses for optimal synchronization.\n​\nMechanism of Action\nElagolix in Eligolux 150 competitively binds GnRH receptors, dose-dependently inhibiting LH/FSH release. This lowers estradiol by 40-60%—less aggressive than 200mg—halting endometrial tissue proliferation outside the uterus. Peak levels hit in 1 hour, with a 4-6 hour half-life supporting steady-state suppression on QD dosing.\n​\nUnlike agonists, no initial hormone surge occurs, preventing worsened pain. Partial estrogen reduction preserves some bone-protective effects, differentiating it from deeper suppression therapies.\n\nKey Benefits\nEligolux 150 shines in clinical responsiveness: phase 3 trials showed 32% dysmenorrhea resolution versus 20% placebo at 6 months, with 50% pain score drops. Quality-of-life gains include better work attendance, sleep, and relationships, per EQ-5D assessments.\n​\nExtended 24-month approval suits long-term control, with amenorrhea in 40-50% of users reducing bleeding volume by 70%. Oral ease beats injectables, enhancing adherence at 85% in studies. Lower BMD impact (0.5-1% loss/year) allows safer continuation versus higher doses.\n\nBenefit\tTrial Data\tPatient Impact\nPain Reduction\t32-50% dysmenorrhea-free \n​\tDaily activity restoration\nBleeding Control\t70% volume drop \n​\tAnemia prevention\nLong-Term Use:\tUp to 24 months \n​\tSustained relief\nQoL Improvement\tEQ-5D gains \n​\tEmotional well-being\nPotential Side Effects\nVasomotor symptoms dominate: hot flashes (20-30%), headaches (17%), and night sweats (10-15%) emerge early but fade. Nausea (8%), insomnia (7%), and mild depression (5%) affect minorities, with a 70% event rate mostly grade 1.\n​\nBMD decline averages -0.9% at the spine after 12 months, monitored via DEXA. Discontinuation hovers at 5-8%.\n\nSide Effect\tIncidence\tMitigation\nHot Flashes\t20-30% \n​\tVentilation, timing\nHeadache\t17% \n​\tAnalgesics\nBMD Loss\t0.9% \n​\tSupplements, scans\nMood Shifts\t5% \n​\tMonitoring\nSerious Risks and Management\nSuicidality (0.1-0.5%) demands baseline psych screening; halt if worsening. Liver enzymes rise in 1%, requiring LFTs at 3/6 months. Rare anaphylaxis or thromboembolism prompts immediate cessation. Avoid in osteoporosis or smokers >35.\n​\n\nDosage Guidelines\n150 mg once daily for up to 24 months in normal/mild liver function; limit to 6 months in moderate impairment (Child-Pugh B). No titration needed; miss a dose? Resume the next day, no doubling. Pair with 1 g calcium/800 IU vitamin D daily.\n​\n\nPrecautions and Contraindications\nPregnancy category X: mandates non-hormonal birth control during and 1 week post-therapy. Screen hepatic/renal function; avoid severe cases. CYP3A interactions (e.g., rifampin reduces efficacy) need dose review. Breastfeeding is contraindicated.\n​\nClinical Evidence and Efficacy\nElaris trials (n=1,689) confirmed superiority: co-primary endpoints met with 75% responder rates for pain. 12-month extensions showed persistent efficacy and low rebound. Versus 200mg, 150mg balances tolerability for moderate pain.\n​\nConclusion\nEligolux 150 empowers women with moderate endometriosis pain through precise, extended hormonal modulation and proven outcomes. Regular physician oversight maximizes safety and efficacy.\n", "price": 700.0, "discountamount": 210.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2252, "imageuri": "https://productimages.withfloats.com/actual/694a2af01e4092f757d90bb5.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2af01e4092f757d90bb5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T10:14:08.773Z", "updatedon": "2026-03-26T05:59:45.544Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/elagolix-150mg-tablet/2252", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 150", "category": "GYANECOLOGYRANGE", "tags": [ "elagolix 150mg tablet", "prioritizing bone health.", "endometriotic pain.", "endometrial tissue proliferation outside the uterus.", "Eligolux 150 empowers women with moderate endometriosis pain through precise.", "hormonal modulation and proven outcomes.", "gonadotropins.", "endometriotic pain." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66680f6300e7d2232cab32fa", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DANOZOLIS 50", "description": "DANOZOLIS 50\nDanazol (50mg)\nDanozolis 50 contains 50mg of Danazol, a synthetic steroid derivative with anti-estrogenic properties. It is primarily used in the treatment of endometriosis, fibrocystic breast disease, and hereditary angioedema. Danazol works by inhibiting the secretion of pituitary gonadotropins, thereby suppressing ovarian function and reducing estrogen levels.\n\nKey Features:\n\nMedication Class: Synthetic steroid derivative\nIndications: Endometriosis, fibrocystic breast disease, hereditary angioedema\nMechanism of Action: Inhibits pituitary gonadotropins, suppresses ovarian function, reduces estrogen levels\nDosage: Typically administered as 50mg capsules\nAdministration: Usually taken orally with or without food\nSide Effects: Possible side effects include weight gain, acne, oily skin, voice changes, and menstrual irregularities.\nPrecautions: Not recommended during pregnancy, lactation, or in patients with liver disease or certain hormone-related disorders. For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \nhttps://www.sterisonline.com/product/danozolis-50-133830", "price": 129.0, "discountamount": 39.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "acne", "food", "Email", "Action", "Danazol", "WhatsApp", "patients", "treatment", "secretion", "oily skin", "DANOZOLIS", "lactation", "pregnancy", "weight gain", "information", "Precautions", "sterispharma", "sterisonline", "Key Features", "endometriosis", "voice changes", "liver disease", "Medication Class", "ovarian function", "Possible side effects", "estrogen levels Dosage", "pituitary gonadotropins", "menstrual irregularities", "hormone-related disorders", "anti-estrogenic properties", "fibrocystic breast disease", "50mg capsules Administration", "hereditary angioedema Mechanism", "Synthetic steroid derivative Indications" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1727, "imageuri": "https://productimages.withfloats.com/actual/667d2fc9c134db5b38ba7565.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/667d2fc9c134db5b38ba7565.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-11T08:48:35.916Z", "updatedon": "2026-03-26T06:22:18.396Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//danozolis-50/1727", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DANOZOLIS 50", "category": "GYANECOLOGYRANGE", "tags": [ "DANOZOLIS 50", "Danazol 50mg tablet", "Danazol 50mg", "danazol 50 mg uses in hindi", "danazol कैप्सूल 100mg आईपी" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6630a3904793c41fd8f760d5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "DANOZOLIS 100 ", "description": "DANOZOLIS 100 \nDanazol (100mg)\nDANOZOLIS 100 is a medication containing Danazol in a strength of 100mg per dosage unit. Danazol is a synthetic steroid derived from ethisterone, primarily used in the treatment of endometriosis, fibrocystic breast disease, and hereditary angioedema. It works by affecting certain hormones in the body to reduce symptoms associated with these conditions.\n\nKey Features of DANOZOLIS 100:\n\nUsage: Prescribed for the management of endometriosis, fibrocystic breast disease, and hereditary angioedema.\nMechanism of Action: Danazol suppresses the pituitary-ovarian axis, inhibiting the release of gonadotropins and thereby reducing estrogen levels.\nDosage: Typically taken orally in divided doses as directed by a healthcare professional.\nSide Effects: Common side effects may include weight gain, acne, oily skin, hot flashes, and changes in menstrual flow.\nPrecautions: It is important to follow dosage instructions carefully and inform your doctor of any existing medical conditions or medications being taken.\nStorage: Store at room temperature away from moisture and heat.\nDANOZOLIS 100, with its Danazol content, plays a crucial role in managing various hormone-related disorders under medical supervision. Always consult a healthcare provider for proper diagnosis and treatment plans tailored to individual needs.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 177.0, "discountamount": 53.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 866, "imageuri": "https://productimages.withfloats.com/actual/6630a3925c30785f2f7b6154.png", "tileimageuri": "https://productimages.withfloats.com/tile/6630a3925c30785f2f7b6154.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-30T07:53:52.304Z", "updatedon": "2026-03-12T11:50:13.605Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//danozolis-100-/866", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Danazol (100mg)", "category": "GYANECOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6a392f71ac59196530375cb2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "cabergoline tablets 0.25 mg", "description": "Cabergoline Tablets 0.25 mg are widely prescribed for the treatment of conditions associated with elevated prolactin levels in the body. This medication belongs to a class of drugs known as dopamine agonists and is highly effective in managing hormonal imbalances that can affect fertility, menstrual health, and pituitary gland function.\n\nPatients searching for cabergoline tablets 0.25 mg, cabergoline 0.25 mg uses, cabergoline tablet price, cabergoline side effects, and cabergoline dosage often want detailed information before making a purchase decision. This comprehensive guide explains everything you need to know about Cabergoline Tablets 0.25 mg, including benefits, mechanism of action, dosage recommendations, precautions, and frequently asked questions.\n\nWhat Are Cabergoline Tablets 0.25 mg?\n\nCabergoline Tablets 0.25 mg contain cabergoline as the active pharmaceutical ingredient. The medicine is primarily used to lower abnormally high prolactin levels in the blood, a condition known as hyperprolactinemia.\n\nHigh prolactin levels can lead to:\n\nIrregular menstrual cycles\nInfertility\nUnwanted breast milk production\nReduced libido\nErectile dysfunction in men\nPituitary gland disorders\n\nCabergoline works by restoring hormonal balance and helping patients regain normal reproductive and endocrine function.\n\nHow Does Cabergoline 0.25 mg Work?\n\nCabergoline acts as a dopamine receptor agonist. Dopamine is a natural chemical in the brain that helps regulate prolactin secretion.\n\nMechanism of Action\n\nThe medication stimulates dopamine D2 receptors located in the pituitary gland. This action suppresses prolactin production and release.\n\nAs prolactin levels decrease:\n\nMenstrual cycles become more regular.\nFertility may improve.\nSymptoms of prolactin-producing tumors may reduce.\nBreast milk production caused by elevated prolactin decreases.\nHormonal balance improves.\n\nThe long duration of action of cabergoline allows for less frequent dosing compared to some alternative therapies.\n\nWhy Is Cabergoline Tablets 0.25 mg Important?\n\nMaintaining normal prolactin levels is crucial for reproductive health and hormonal stability.\n\nUntreated hyperprolactinemia may lead to:\n\nInfertility\nMenstrual disorders\nOsteoporosis\nSexual dysfunction\nPituitary tumor progression\n\nCabergoline Tablets 0.25 mg help address the root cause of these symptoms and improve overall quality of life.\n\nKey Benefits of Cabergoline Tablets 0.25 mg\nEffective Prolactin Control\n\nCabergoline significantly lowers elevated prolactin levels and helps restore hormonal balance.\n\nImproves Fertility\n\nWomen struggling with infertility due to elevated prolactin levels may experience improved reproductive function.\n\nRestores Menstrual Regularity\n\nThe medication helps normalize menstrual cycles in women with hormonal imbalances.\n\nReduces Galactorrhea\n\nCabergoline effectively decreases inappropriate breast milk production.\n\nSupports Pituitary Health\n\nIt helps manage prolactin-secreting pituitary tumors (prolactinomas).\n\nConvenient Dosing Schedule\n\nDue to its long half-life, Cabergoline often requires fewer doses per week than many alternative medications.\n\nIndications of Cabergoline Tablets 0.25 mg\n\nDoctors commonly prescribe Cabergoline Tablets 0.25 mg for:\n\nHyperprolactinemia\nProlactin-secreting pituitary adenomas (prolactinomas)\nMenstrual irregularities caused by elevated prolactin\nFemale infertility associated with high prolactin\nGalactorrhea\nHormonal imbalance disorders\nCertain endocrine conditions requiring prolactin suppression\nEfficacy and Clinical Evidence\n\nClinical studies have consistently demonstrated the effectiveness of cabergoline in reducing prolactin levels.\n\nResearch has shown that Cabergoline:\n\nProduces significant prolactin reduction\nRestores ovulation in many women\nImproves fertility outcomes\nReduces tumor size in prolactinoma patients\nOffers long-term symptom control\n\nIts favorable efficacy profile makes it one of the most commonly prescribed dopamine agonists for hyperprolactinemia management.\n\nDosage Guidelines for Cabergoline Tablets 0.25 mg\n\nAlways follow your healthcare provider's instructions.\n\nTypical Dosage\n\nThe dosage depends on:\n\nSeverity of the condition\nProlactin levels\nPatient response\nMedical history\n\nTreatment usually begins with a low dose and may be adjusted gradually based on clinical response.\n\nAdministration Tips\nTake the tablet exactly as prescribed.\nSwallow with water.\nCan be taken with food to minimize stomach discomfort.\nMaintain a consistent dosing schedule.\nMissed Dose\n\nIf you miss a dose:\n\nTake it as soon as remembered.\nSkip if the next scheduled dose is near.\nNever double the dose.\nSide Effects of Cabergoline Tablets 0.25 mg\n\nLike all medicines, Cabergoline may cause side effects.\n\nCommon Side Effects\nNausea\nHeadache\nDizziness\nFatigue\nConstipation\nAbdominal discomfort\nLow blood pressure\nSleepiness\n\nMost side effects are mild and improve as the body adjusts to treatment.\n\nSerious Side Effects\n\nSeek immediate medical attention if you experience:\n\nChest pain\nShortness of breath\nSevere dizziness\nPersistent swelling\nFainting episodes\nSevere allergic reactions\nSignificant mood changes\nPrecautions and Warnings\n\nBefore using Cabergoline Tablets 0.25 mg, inform your doctor if you have:\n\nHeart Disease\n\nPatients with cardiovascular conditions require careful monitoring.\n\nLiver Disorders\n\nDose adjustments may be necessary in certain cases.\n\nPregnancy\n\nUse only when specifically prescribed by a healthcare provider.\n\nBreastfeeding\n\nConsult your physician before taking Cabergoline during breastfeeding.\n\nMental Health Conditions\n\nPatients with psychiatric disorders should discuss their medical history with their doctor.\n\nLow Blood Pressure\n\nCabergoline may further reduce blood pressure in susceptible individuals.\n\nDrug Interactions\n\nCabergoline may interact with:\n\nAntipsychotic medications\nBlood pressure medications\nDopamine antagonists\nCertain antibiotics\nOther hormonal therapies\n\nAlways inform your doctor about all medications and supplements you are taking.\n\nCabergoline Tablets 0.25 mg Price\n\nPatients frequently search for information regarding cabergoline tablet price before purchasing treatment.\n\nThe cost may vary depending on:\n\nBrand\nPharmacy location\nPack size\nAvailability\nPrescription requirements\n\nFor accurate pricing and availability, consult your local pharmacy or authorized pharmaceutical distributor.\n\nStorage Instructions\nStore below recommended room temperature.\nKeep away from moisture and direct sunlight.\nKeep out of reach of children.\nWhy Choose Steris Healthcare Products?\n\nSteris Healthcare Pvt. Ltd. is committed to delivering high-quality pharmaceutical products manufactured under strict quality standards.\n\nAdvantages Include:\nWHO-GMP certified manufacturing facilities\nStringent quality control\nReliable pharmaceutical formulations\nPatient-focused healthcare solutions\nConsistent product quality\n\nHealthcare professionals trust Steris Healthcare for dependable pharmaceutical products that meet industry standards.\n\nConclusion\n\nCabergoline Tablets 0.25 mg are an effective treatment option for managing elevated prolactin levels, prolactinomas, hormonal imbalance, infertility, and related endocrine disorders. By acting directly on dopamine receptors, the medication helps restore normal prolactin levels and improves reproductive health outcomes.\n\nPatients seeking a proven therapy for hyperprolactinemia often benefit from the convenience, efficacy, and long-lasting action of Cabergoline. However, treatment should always be undertaken under medical supervision with regular monitoring and follow-up.\n\nFrequently Asked Questions (FAQs)\nWhat is Cabergoline Tablets 0.25 mg used for?\n\nCabergoline Tablets 0.25 mg are primarily used to treat hyperprolactinemia, prolactinomas, infertility associated with high prolactin levels, and hormonal disorders.\n\nHow does Cabergoline work?\n\nCabergoline stimulates dopamine receptors in the pituitary gland, reducing prolactin production and restoring hormonal balance.\n\nCan Cabergoline improve fertility?\n\nYes. In many women, lowering elevated prolactin levels can help restore ovulation and improve fertility.\n\nHow long does Cabergoline take to work?\n\nMany patients experience a reduction in prolactin levels within a few weeks, although results vary depending on the condition being treated.\n\nWhat are the common side effects of Cabergoline?\n\nCommon side effects include nausea, headache, dizziness, constipation, fatigue, and abdominal discomfort.\n\nCan Cabergoline be taken with food?\n\nYes. Taking Cabergoline with food may help reduce stomach-related side effects.\n\nIs Cabergoline safe for long-term use?\n\nWhen prescribed and monitored by a healthcare professional, Cabergoline can be used safely for long-term treatment in appropriate patients.\n\nCan men take Cabergoline Tablets 0.25 mg?\n\nYes. Men with elevated prolactin levels or prolactin-related disorders may benefit from Cabergoline therapy.\n\nIs a prescription required for Cabergoline?\n\nYes. Cabergoline Tablets 0.25 mg are prescription-only medications and should be used under medical supervision.\n\nHow should Cabergoline tablets be stored?\n\nStore the medication in a cool, dry place away from moisture, sunlight, and the reach of children.\nProduct Information Template\n\n", "price": 240.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2457, "imageuri": "https://productimages.withfloats.com/actual/6a392f73cf03f058fecf81dc.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a392f73cf03f058fecf81dc.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-22T12:49:53.333Z", "updatedon": "2026-06-22T12:49:53.333Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//cabergoline-tablets-0-25-mg/2457", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CABERGLOW 0.25", "category": "GYANECOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6a2d48afac0355b28788bcbe", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Relugolix 40 mg estradiol 1 mg norethisterone", "description": "Women suffering from heavy menstrual bleeding caused by uterine fibroids or pain associated with endometriosis often face challenges that affect their quality of life, daily activities, and overall well-being. Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg is an advanced oral therapy specifically developed to address these conditions while maintaining hormonal balance and reducing treatment-related side effects.\n\nThis innovative combination treatment offers a non-surgical approach for managing symptoms such as excessive menstrual bleeding, pelvic pain, and discomfort caused by hormone-dependent gynecological disorders. If you are searching for an effective and clinically proven treatment option, understanding the benefits, mechanism of action, uses, and safety profile of Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg can help you make an informed healthcare decision.\n\nWhat is Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg?\n\nRelugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg is a prescription medication used for the management of:\n\nHeavy menstrual bleeding associated with uterine fibroids\nModerate to severe pain associated with endometriosis\nHormone-dependent gynecological conditions requiring long-term symptom control\n\nThe combination contains three active ingredients that work together to reduce symptoms while minimizing the adverse effects commonly associated with hormone suppression therapies.\n\nComposition of Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg\nRelugolix 40 mg\n\nRelugolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist. It works by reducing the production of estrogen and progesterone from the ovaries, helping control the growth and symptoms of hormone-sensitive conditions.\n\nEstradiol 1 mg\n\nEstradiol is a form of estrogen included to maintain healthy estrogen levels and help prevent symptoms associated with estrogen deficiency.\n\nNorethisterone Acetate 0.5 mg\n\nNorethisterone acetate is a synthetic progestin that helps protect the uterine lining and contributes to hormonal balance during treatment.\n\nTogether, these ingredients create a balanced therapy that effectively manages symptoms while reducing the risk of bone density loss and menopausal-like side effects.\n\nHow Does Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg Work?\n\nThe medication utilizes a unique combination approach.\n\nSuppresses Excess Hormonal Activity\n\nRelugolix blocks GnRH receptors in the pituitary gland, reducing the release of hormones that stimulate ovarian estrogen production.\n\nReduces Fibroid-Related Bleeding\n\nLower estrogen levels help decrease fibroid activity, reducing heavy menstrual bleeding and improving quality of life.\n\nControls Endometriosis Symptoms\n\nBy suppressing estrogen production, Relugolix helps reduce the growth and activity of endometrial tissue outside the uterus, decreasing pain and inflammation.\n\nMaintains Hormonal Balance\n\nEstradiol and Norethisterone Acetate are added to provide “add-back therapy,” helping maintain hormonal balance and reducing the likelihood of menopausal symptoms.\n\nWhy is Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg Important?\n\nWomen with uterine fibroids and endometriosis often experience symptoms that interfere with daily life, including:\n\nExcessive menstrual bleeding\nSevere pelvic pain\nPainful periods\nFatigue caused by anemia\nPain during intercourse\nReduced productivity and quality of life\n\nThis combination treatment offers effective symptom management while helping patients avoid or delay surgical interventions in many cases.\n\nUses of Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg\nHeavy Menstrual Bleeding Due to Uterine Fibroids\n\nThe medication significantly reduces menstrual blood loss associated with uterine fibroids.\n\nManagement of Endometriosis Pain\n\nIt helps control moderate to severe pain caused by endometriosis.\n\nLong-Term Symptom Control\n\nSuitable for patients requiring sustained symptom management under medical supervision.\n\nHormone-Dependent Gynecological Disorders\n\nMay be prescribed as part of a comprehensive treatment plan for selected hormone-sensitive conditions.\n\nKey Benefits of Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg\nEffective Reduction of Heavy Menstrual Bleeding\n\nOne of the most significant benefits is the ability to substantially reduce excessive menstrual blood loss.\n\nImproved Pelvic Pain Management\n\nMany patients experience noticeable relief from endometriosis-related pelvic pain.\n\nNon-Surgical Treatment Option\n\nProvides an effective alternative to invasive procedures for suitable patients.\n\nMaintains Bone Health\n\nThe addition of Estradiol and Norethisterone Acetate helps reduce bone mineral density loss associated with hormone suppression.\n\nImproved Quality of Life\n\nPatients often report better physical comfort, improved energy levels, and enhanced daily functioning.\n\nConvenient Oral Administration\n\nThe once-daily oral tablet offers convenience and ease of use compared to injectable therapies.\n\nWho Can Benefit from Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg?\n\nThis medication may be recommended for:\n\nWomen with symptomatic uterine fibroids\nPatients experiencing heavy menstrual bleeding\nWomen diagnosed with endometriosis\nIndividuals seeking non-surgical treatment options\nPatients requiring long-term symptom management\n\nA healthcare provider will determine whether this therapy is appropriate based on individual medical history and treatment goals.\n\nHow to Take Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg\n\nFor optimal results:\n\nTake exactly as prescribed by your healthcare provider.\nUsually taken once daily.\nCan generally be taken with or without food.\nTake at the same time each day for consistent hormone control.\nDo not skip doses unless advised by your doctor.\n\nRegular follow-up appointments may be necessary to monitor treatment effectiveness and safety.\n\nPossible Side Effects\n\nLike all medications, side effects may occur.\n\nCommon Side Effects\nHot flashes\nHeadache\nFatigue\nMood changes\nIrregular bleeding\nNight sweats\nMild gastrointestinal discomfort\n\nMany side effects are mild and improve as treatment continues.\n\nLess Common Side Effects\nWeight changes\nBreast tenderness\nDizziness\nSleep disturbances\nSerious Side Effects\n\nSeek immediate medical attention if you experience:\n\nSigns of blood clots\nSevere allergic reactions\nSignificant mood changes\nUnusual vaginal bleeding\nChest pain or shortness of breath\nImportant Safety Information\n\nBefore starting treatment, inform your healthcare provider if you have:\n\nHistory of blood clots\nCardiovascular disease\nLiver disease\nOsteoporosis\nHormone-sensitive cancers\nUnexplained vaginal bleeding\nSmoking history, especially over age 35\n\nA complete medical evaluation is essential before initiating therapy.\n\nDrug Interactions\n\nCertain medications may interact with Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg.\n\nExamples include:\n\nHormonal therapies\nAnticonvulsants\nCertain antibiotics\nAntifungal medications\nBlood thinners\nSome HIV medications\n\nAlways provide your doctor with a full list of medications and supplements you are taking.\n\nFrequently Asked Questions\nCan this medication cure uterine fibroids?\n\nNo. It helps manage symptoms and reduce bleeding but does not permanently eliminate fibroids.\n\nHow quickly does it start working?\n\nMany patients notice symptom improvement within the first few weeks of treatment, though individual responses vary.\n\nCan it help avoid surgery?\n\nIn some patients, symptom control may reduce the immediate need for surgical intervention. Your doctor will determine the best treatment approach.\n\nIs long-term use possible?\n\nTreatment duration depends on individual circumstances and medical supervision.\n\nCan it be used during pregnancy?\n\nNo. This medication should not be used during pregnancy. Effective contraception may be recommended during treatment.\n\nWhy Choose Relugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg?\n\nThis advanced combination therapy offers a balanced approach to managing uterine fibroids and endometriosis. By combining hormone suppression with carefully selected hormone replacement components, it provides effective symptom relief while minimizing common treatment-related side effects.\n\nIts ability to reduce heavy menstrual bleeding, improve pelvic pain, support bone health, and offer a convenient oral dosing schedule makes it a preferred treatment option for many women seeking comprehensive symptom management.\n\nConclusion\n\nRelugolix 40 mg, Estradiol 1 mg & Norethisterone Acetate 0.5 mg is a modern and effective therapy for women suffering from heavy menstrual bleeding associated with uterine fibroids and pain related to endometriosis. Through its unique combination of Relugolix, Estradiol, and Norethisterone Acetate, the medication helps control symptoms, improve quality of life, and provide a non-surgical treatment alternative.", "price": 845.0, "discountamount": 254.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2453, "imageuri": "https://productimages.withfloats.com/actual/6a2d48b1bb059c34f7b06bbe.png", "tileimageuri": "https://productimages.withfloats.com/tile/6a2d48b1bb059c34f7b06bbe.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-06-13T12:10:23.243Z", "updatedon": "2026-06-13T12:10:23.243Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//relugolix-40-mg-estradiol-1-mg-norethisterone/2453", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RELUGOLINE 40/1/0.5", "category": "GYANECOLOGYRANGE", "tags": [ "relugolix 40 mg estradiol 1 mg norethisterone", "relugolix 40 mg estradiol 1 mg norethindrone acetate 0.5 mg tablet", "Buy Relugolix Estradiol Norethisterone Tablets Online", "Relugolix Combination Tablets for Uterine Fibroids", "Relugolix 40 mg Women's Health Medicine", "Relugolix 40 mg Estradiol 1 mg Norethisterone Product Image", "Best Relugolix Combination Tablets for Fibroid Management", "relugolix tablets for heavy menstrual bleeding in india", "Buy Relugolix 40 mg Estradiol 1 mg Tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "698eccba9206f8f071919fc7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "clobetasol neomycin miconazole cream", "description": "EUROSOFT 4D CREAM represents a sophisticated breakthrough in topical dermatological therapy, combining three powerful active ingredients—clobetasol propionate, neomycin sulfate, and miconazole nitrate—into one comprehensive treatment formulation. This advanced pharmaceutical preparation is specifically designed to address complex skin conditions that involve inflammation, bacterial infection, and fungal colonization simultaneously. The “4D” designation reflects the cream's multidimensional approach to skin healing: it reduces inflammation, eliminates bacterial pathogens, eradicates fungal infections, and promotes overall skin restoration.This prescription-strength cream has been formulated using advanced pharmaceutical technology to ensure optimal penetration, stability, and efficacy. Each gram of EUROSOFT 4D CREAM delivers precise therapeutic doses of its active components, working synergistically to provide rapid relief and comprehensive healing for challenging dermatological conditions that might otherwise require multiple separate medications.Comprehensive Uses and ApplicationsEUROSOFT 4D CREAM is prescribed for a diverse range of dermatological conditions where multiple pathogenic factors contribute to skin disease. The primary indications include infected eczema, where both inflammation and secondary bacterial or fungal infection complicate the condition. Patients suffering from seborrheic dermatitis with secondary infection find significant relief with this triple-action formulation, as it addresses both the inflammatory component and the microbial colonization that often perpetuates this chronic condition.The cream proves particularly valuable in treating intertrigo—inflammatory conditions occurring in skin folds—where moisture, friction, and warmth create an ideal environment for both bacterial and fungal proliferation alongside inflammatory responses. Athletes dealing with infected dermatoses, including cases where fungal infections like tinea have become complicated by bacterial superinfection, benefit from the comprehensive coverage this medication provides.Contact dermatitis cases that have developed secondary infections respond well to EUROSOFT 4D CREAM, as the corticosteroid component addresses the allergic or irritant inflammatory response while the antimicrobial agents tackle opportunistic infections. The cream is also employed in managing various forms of infected psoriasis, particularly in intertriginous areas where both inflammation and infection coexist, creating a challenging therapeutic scenario.Medical professionals may prescribe this formulation for other complex dermatological conditions where the simultaneous presence of inflammation, bacterial infection, and fungal colonization requires a multifaceted treatment approach. The convenience of a single application containing all three therapeutic agents significantly improves patient compliance compared to using multiple separate medications.Key Benefits and Therapeutic AdvantagesThe primary advantage of EUROSOFT 4D CREAM lies in its comprehensive, multi-targeted action. The clobetasol propionate component is a super-potent corticosteroid that rapidly suppresses inflammation, reducing redness, swelling, itching, and discomfort. This powerful anti-inflammatory effect provides quick symptomatic relief, often noticeable within the first few applications, dramatically improving patient comfort and quality of life.Neomycin sulfate, a broad-spectrum aminoglycoside antibiotic, effectively eliminates a wide range of gram-positive and gram-negative bacteria commonly responsible for secondary skin infections. By controlling bacterial proliferation, it prevents infection from spreading, reduces the risk of complications, and accelerates the healing process. This antibacterial protection is crucial in preventing the vicious cycle where infection perpetuates inflammation and vice versa.The miconazole nitrate component provides robust antifungal coverage against dermatophytes, yeasts, and other pathogenic fungi that frequently complicate inflammatory skin conditions. Its fungicidal action ensures complete eradication of fungal elements, preventing recurrence and breaking the cycle of persistent infection that can undermine other therapeutic efforts.The synergistic formulation means patients need only one medication rather than juggling multiple creams or ointments, significantly simplifying their treatment regimen. This convenience improves adherence to prescribed therapy, leading to better outcomes. The cream base is designed for optimal absorption and comfortable application, avoiding the greasiness or stickiness that might deter regular use.EUROSOFT 4D CREAM typically produces visible improvements within days, though complete resolution requires completing the full prescribed course. The rapid symptom relief—particularly reduction in itching, pain, and visible inflammation—provides significant psychological and physical comfort to patients struggling with distressing skin conditions. By addressing all three pathological factors simultaneously, the cream prevents the common problem of treating one aspect of the condition while another remains unaddressed and continues causing symptoms.Important Side Effects and PrecautionsWhile EUROSOFT 4D CREAM is highly effective, users should be aware of potential side effects associated with its potent active ingredients. The clobetasol component, being a super-potent corticosteroid, can cause skin thinning (atrophy), stretch marks (striae), telangiectasia (visible blood vessels), and changes in skin pigmentation with prolonged use. These effects are more likely when the cream is used on thin-skinned areas like the face, groin, or underarms, or when applied under occlusive dressings.Systemic absorption of clobetasol, particularly with extensive application or prolonged use, may suppress the hypothalamic-pituitary-adrenal (HPA) axis, potentially affecting the body's natural cortisol production. This is especially concerning in children, whose body surface area to weight ratio makes them more vulnerable to systemic effects. Other corticosteroid-related effects may include acne-like eruptions, perioral dermatitis, delayed wound healing, and increased susceptibility to skin infections if protective immunity is compromised.Neomycin can cause contact sensitization in susceptible individuals, leading to allergic contact dermatitis. This manifests as increased redness, itching, or rash that paradoxically worsens with continued use. Cross-sensitivity with other aminoglycoside antibiotics is possible. Though rare with topical application, systemic absorption of neomycin could theoretically cause ototoxicity or nephrotoxicity, particularly if applied to large surface areas or compromised skin.Miconazole is generally well-tolerated but can occasionally cause local irritation, burning, or allergic reactions. Some users report mild stinging upon initial application, which typically subsides with continued use.Users should avoid applying the cream to the face for extended periods, near the eyes, or on broken skin unless specifically directed by their healthcare provider. The medication should not be used during pregnancy or breastfeeding without medical supervision. Parents should exercise particular caution when using this cream on children, as pediatric patients are more susceptible to systemic corticosteroid effects.If symptoms worsen, if new symptoms develop, or if no improvement occurs after one week of use, patients should consult their healthcare provider promptly. Signs of possible adverse reactions include excessive irritation, severe itching, rash expansion, or signs of spreading infection.ConclusionEUROSOFT 4D CREAM represents an innovative and highly effective solution for complex dermatological conditions requiring simultaneous anti-inflammatory, antibacterial, and antifungal therapy. Its triple-action formulation addresses the multifaceted nature of infected inflammatory skin diseases, providing comprehensive treatment in a single convenient application. The synergistic combination of clobetasol propionate, neomycin sulfate, and miconazole nitrate delivers rapid symptom relief while promoting complete healing.", "price": 91.0, "discountamount": 27.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2302, "imageuri": "https://productimages.withfloats.com/actual/698eccbd3d2f9770ce0bdd1c.png", "tileimageuri": "https://productimages.withfloats.com/tile/698eccbd3d2f9770ce0bdd1c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-02-13T07:03:22.253Z", "updatedon": "2026-03-12T08:14:48.969Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//clobetasol-neomycin-miconazole-cream/2302", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "EUROSOFT 4D CREAM", "category": "DERMATALOGY", "tags": [ "Clobetasol Neomycin Miconazole cream", "Clobetasol combination antifungal cream", "Clobetasol Neomycin Miconazole Chlorhexidine cream", "Triple action steroid antibiotic antifungal cream", "Miconazole Neomycin steroid skin cream", "Clobetasol Neomycin antifungal cream 0.5%" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948f4ee5837f90c86a7e578", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Elagolix 200mg ", "description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n​\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n​\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n​\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n​\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n​\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n​\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n​\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n​\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n​\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n​\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n​\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n​\tDEXA scans, supplements\nMood Changes\tLess common \n​\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n​\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near the next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n​\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n​\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n​\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n​\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n", "price": 1000.0, "discountamount": 300.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2251, "imageuri": "https://productimages.withfloats.com/actual/694a2b9f403179ac7e958ef6.png", "tileimageuri": "https://productimages.withfloats.com/tile/694a2b9f403179ac7e958ef6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T07:36:14.316Z", "updatedon": "2026-03-26T06:00:31.59Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//elagolix-200mg-/2251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 200", "category": "GYANECOLOGYRANGE", "tags": [ "Elagolix Tablets 200mg", "Elagolix acts as a potent gonadotropin-releasing hormone.", "nonmenstrual pelvic pain.", "adhesions, and scarring", "preserving bone health better than monotherapy.", "avoiding invasive laparoscopies and reclaiming normalcy.", "pituitary gland to rapidly reduce estrogen and progesterone.", "tab elagolix 200mg", "elagolix 200mg.", "elagolix.", "elagolix 200.", "elagolix tablets", "elagolix tablets uses.", "elagolix 200 mg price.", "elagolix mechanism of action.", "elagolix 200 mg uses.", "tab elagolixtab elagolix." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662d38c8e599e12c0eabdc2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CABERGLOW 0.50 ", "description": "CABERGLOW 0.50 \nCabergoline IP(0.5mg)\nCABERGLOW 0.50, containing Cabergoline IP 0.5mg, is a medication used primarily to treat hyperprolactinemia, a condition characterized by high levels of prolactin hormone in the blood. Cabergoline works by reducing the production of prolactin from the pituitary gland in the brain.\n\nThis medication is commonly prescribed to treat conditions such as prolactin-secreting adenomas (tumors of the pituitary gland that produce prolactin), which can lead to symptoms like irregular menstrual periods, infertility, and breast milk production in non-pregnant individuals.\n\nCabergoline is also used off-label in some cases to treat symptoms of Parkinson's disease due to its dopamine agonist properties, which help improve motor functions.\n\nIt is important to take Cabergoline exactly as prescribed by your healthcare provider to achieve the best results. Common side effects may include nausea, dizziness, headache, and fatigue. It's essential to discuss any concerns or side effects with your doctor while taking CABERGLOW 0.50.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nOrder Now: \n\nhttps://www.sterisonline.com/product/caberglow-0-50-133819\n\n\n\n\n\n\n\n", "price": 331.0, "discountamount": 100.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "Call", "label", "Order", "brain", "Email", "blood", "cases", "tumors", "nausea", "doctor", "fatigue", "disease", "headache", "symptoms", "WhatsApp", "concerns", "dizziness", "CABERGLOW", "condition", "Parkinson", "medication", "information", "high levels", "infertility", "sterispharma", "sterisonline", "best results", "Cabergoline IP", "motor functions", "pituitary gland", "prolactin hormone", "hyperprolactinemia", "healthcare provider", "Common side effects", "pregnant individuals", "breast milk production", "dopamine agonist properties", "irregular menstrual periods", "prolactin-secreting adenomas" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1523, "imageuri": "https://productimages.withfloats.com/actual/667d2ce55443982e2f65479a.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d2ce55443982e2f65479a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T09:31:56.802Z", "updatedon": "2026-03-14T09:25:19.475Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//caberglow-0-50-/1523", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CABERGLOW 0.50 ", "category": "GENERAL RANGE", "tags": [ "cabergoline 0.5mg tablet uses", "cabergoline side effects", "cabergoline tablets ip 0.5 uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6abe4471401ae1a1106d67d9", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Bisoprolol 1.25mg", "description": "Bisoprolol 1.25mg is the smallest tablet strength of bisoprolol, a heart-selective beta-1 blocker. Doctors usually prescribe it to start treatment or to build up the dose gradually in people with high blood pressure, chronic stable heart failure, or fast heart rhythms. It suits older adults, people with mild heart failure, and anyone who reacts strongly to beta-blockers. The medicine slows the heartbeat and eases the force of each contraction, so the heart works less hard. BISOGARD 1.25 from Steris Healthcare Pvt. Ltd. comes in a strip pack of 15 tablets. It is a Schedule H medicine, so it must only be started, changed, or stopped on a doctor's advice.\n\nProduct Snapshot\n\nBrand: BISOGARD 1.25\nManufacturer/Marketer: Steris Healthcare Pvt. Ltd., a WHO-GMP and ISO-certified pharmaceutical company in India\nActive ingredient: Bisoprolol Fumarate 1.25mg\nForm: Tablet\nPack size: 15 tablets\nDrug class: Cardioselective beta-1 blocker\nLegal status: Schedule H (valid prescription required)\nAvailability: Through Steris Healthcare's authorized pharmacies and its B2B PCD franchise network across India\nWhat Is Bisoprolol 1.25mg?\n\nIf your doctor has just prescribed bisoprolol 1.25mg, you have been given the lowest dose on purpose. Bisoprolol is a cardioselective beta-1 blocker, meaning it acts mostly on receptors in the heart and has much less effect on the lungs and blood vessels. This is a major reason it is preferred over older, non-selective beta-blockers, especially for people who also have a mild breathing problem.\n\nThe 1.25mg tablet is not a “light” medicine for mild illness. It is a carefully chosen entry point. In heart failure, a weakened heart can struggle if its rate or pressure drops too quickly, so cardiologists follow a “start low, go slow” approach. Treatment begins at 1.25mg, the response is watched for one to two weeks, and the dose is raised step by step (commonly 2.5mg, 3.75mg, 5mg, 7.5mg, and up to 10mg) as the heart adapts. That is why BISOGARD 1.25 is often the first tablet a newly diagnosed heart failure patient takes.\n\nWhat Is Bisoprolol 1.25mg Used For?\n\nDoctors commonly prescribe this strength for:\n\nChronic heart failure (HFrEF): as the first step of dose titration in patients with a reduced ejection fraction, alongside ACE inhibitors/ARBs and diuretics\nHigh blood pressure: especially in older adults, people with low body weight, and those who are sensitive to blood-pressure-lowering drugs\nStable angina: to reduce the heart's oxygen demand and relieve chest discomfort\nAfter a heart attack: in selected patients, under a cardiologist's care\nHeart rate control in some arrhythmias: sometimes used off-label at a low dose to gently bring down a fast heart rate\n\nAt 1.25mg, bisoprolol is seldom meant as the long-term sole treatment for high blood pressure in an otherwise healthy adult. It is usually the first rung of a titration ladder, or a steady maintenance dose for patients who are unusually beta-blocker sensitive (older age, low body weight, or borderline low pressure or pulse).\n\nHow Does Bisoprolol Work?\n\nBisoprolol selectively blocks beta-1 adrenergic receptors, which are packed mainly into heart muscle. This leads to several effects:\n\nSlower heart rate: the heart has more time to fill and rest between beats\nGentler contractions: the heart muscle needs less oxygen and energy\nLess renin from the kidneys: this helps blood pressure fall gradually over time\nLower overall cardiac workload: a real advantage for a heart that already struggles to pump well, as in heart failure\nKey Benefits of BISOGARD 1.25\nA gentle starting dose, well suited to careful titration in frail or elderly patients\nHeart-focused action, with less effect on the lungs and peripheral blood vessels than non-selective beta-blockers\nOnce-daily dosing, which makes it easier to stay on treatment\nA guideline-recommended beta-blocker for HFrEF with well-established outcomes data [Reviewer note: insert specific outcome statistics/trial citation pending medical sign-off]\nMade by Steris Healthcare Pvt. Ltd. under WHO-GMP and ISO-certified standards\nDosage Guidance\nUsual starting dose (heart failure): 1.25mg once a day, preferably in the morning\nDose increases: typically every 1–2 weeks (2.5mg, 3.75mg, 5mg, 7.5mg, up to a maximum of 10mg daily), depending on how well you tolerate it and on your pulse and blood pressure\nHigh blood pressure (sensitive patients): 1.25mg to 5mg once daily, as set by your doctor\nHow to take it: at the same time every day, with or without food, swallowed whole with water\nIf you miss a dose: take it when you remember, unless the next dose is almost due. Never take a double dose.\nNever stop suddenly: abrupt withdrawal can cause a rebound rise in heart rate, blood pressure, or chest pain. The dose must be reduced gradually under medical supervision.\nIs It Better to Take Bisoprolol in the Morning or at Night?\n\nMost doctors advise a morning dose. Bisoprolol lowers pulse and blood pressure, and taking it early matches its action to your daytime activity. A night-time dose could add to the body's natural overnight dip in blood pressure and raise the chance of dizziness when getting up in the dark. Some people who feel tired during the day are told by their doctor to switch to the evening. Do not change your dosing time without your doctor's approval.\n\nSide Effects of Bisoprolol 1.25mg\n\nCommon side effects\n\nTiredness or fatigue\nDizziness or light-headedness, especially on standing quickly\nCold hands or feet\nSlow pulse (bradycardia)\nHeadache\nMild stomach upset (nausea, loose stools)\nDisturbed sleep\n\nSerious side effects (get medical help promptly)\n\nVery slow heartbeat or fainting\nIncreasing breathlessness or swollen legs/ankles, which may mean heart failure is worsening\nAllergic reaction: rash, swelling of the face or throat, trouble breathing\nCold, numb, or bluish fingers and toes\nWheezing or new breathing difficulty, particularly in people with asthma or COPD\nMood changes, low mood, or confusion\nWhat Are the Bad Side Effects of Bisoprolol?\n\nThe effects that need urgent attention are a dangerously slow pulse, fainting, signs of worsening heart failure (swelling, breathlessness), severe allergic reactions, and airway tightening in people with lung disease. These are uncommon at the 1.25mg dose, but anyone who notices them should seek medical help right away. [Reviewer note: specific incidence rates pending clinical/medical sign-off]\n\nSubstitutes & Comparable Beta-Blockers\nMolecule\tSelectivity\tTypical Use Case\nBisoprolol\tHighly cardioselective\tHeart failure titration, hypertension\nMetoprolol Succinate ER\tCardioselective\tHypertension, angina, heart failure\nAtenolol\tCardioselective (older agent)\tHypertension\nCarvedilol\tNon-selective with alpha-blocking action\tHeart failure (adds vasodilation)\nPropranolol\tNon-selective\tMigraine prevention, anxiety-related fast heartbeat, essential tremor\nPrecautions & Who Should Avoid Bisoprolol\nNot suitable for people with severe bradycardia, certain forms of heart block (unless a pacemaker is fitted), unstable or acutely decompensated heart failure, or severe uncontrolled asthma\nUse carefully in diabetes, because beta-blockers can hide the warning signs of low blood sugar\nTake care in peripheral vascular disease, as cold extremities or leg pain on walking may worsen\nNever stop it abruptly; always taper under a doctor's guidance\nTell your doctor about every medicine you use, especially other blood-pressure drugs, calcium channel blockers, and certain antiarrhythmics\nIn pregnancy and breastfeeding, use only if your doctor advises it after weighing benefits and risks\nIs Bisoprolol Safe for Kidneys?\n\nThe body clears bisoprolol through both the liver and the kidneys in roughly equal measure. It is generally considered safe for people with normal or mildly reduced kidney function. When kidney impairment is significant, drug levels in the blood can rise, so your doctor may lower the dose or monitor you more closely. Always tell your prescriber about any kidney disease before starting.\n\nIs Bisoprolol a High-Risk Medication?\n\nBisoprolol is not a narrow therapeutic index drug like tacrolimus or warfarin, where small dose differences matter greatly. Even so, it needs supervised use because it directly affects heart rate and blood pressure. The main dangers are stopping it suddenly, which can set off rebound cardiac events, and using it with certain existing rhythm disorders. Taken as prescribed and checked regularly, it has a long and reassuring safety record.\n\nDoes 1.25mg Bisoprolol Lower Blood Pressure?\n\nYes. Even the smallest dose measurably reduces heart rate and blood pressure by lightening the heart's workload and reducing renin-driven narrowing of blood vessels. At this strength the effect on blood pressure is fairly mild, which is exactly why it is a safe place to begin, especially for older adults or people starting heart failure treatment. The dose is then raised gradually to reach full benefit.\n\nFrequently Asked Questions\n\n1. What is 1.25 mg of bisoprolol used for?\nMainly as a low starting dose when building up treatment for chronic heart failure, and for high blood pressure in people who are very sensitive to beta-blockers, such as older adults.\n\n2. What are the bad side effects of bisoprolol?\nThe more serious ones are a very slow pulse, fainting, worsening heart failure signs (swelling, breathlessness), severe allergy, and breathing trouble in people with lung conditions.\n\n3. What are the common side effects of bisoprolol fumarate 1.25 mg tablets?\nTiredness, dizziness, cold hands and feet, mild headache, and a slightly slower pulse.\n\n4. Is it better to take bisoprolol in the morning or at night?\nMorning is usually preferred so its effect fits daytime activity, though your doctor may suggest evenings in some cases.\n\n5. What is the cost of bisoprolol?\nPrice depends on strength, pack size, and brand. Use the “Check Price” option above for current BISOGARD 1.25 pricing from Steris Healthcare.\n\n6. Does 1.25 mg bisoprolol lower blood pressure?\nYes, though only modestly at this dose. The dose is often stepped up over time.\n\n7. Is bisoprolol safe for kidneys?\nGenerally yes for normal or mildly reduced kidney function. People with significant kidney impairment need dose adjustment and monitoring.\n\n8. Is bisoprolol a high-risk medication?\nIt is not a narrow therapeutic index drug, but it must never be stopped suddenly and should be used under medical supervision because of its direct effect on the heart.\n\n9. Can I take bisoprolol 1.25mg for the rest of my life?\nMany people with chronic heart failure or hypertension do take bisoprolol long term, but the dose usually rises as tolerated. Your doctor should review it regularly.\n\n10. What happens if I miss a dose of bisoprolol?\nTake it when you remember, unless the next dose is nearly due. In that case skip the missed one. Never take two together.\n\n11. Can bisoprolol 1.25mg cause weight gain?\nIt is not commonly reported at this dose. Fluid retention linked to heart failure itself should be reported to your doctor.\n\n12. Is bisoprolol safe for diabetic patients?\nIt can be used, with care, because beta-blockers may hide warning signs of low blood sugar such as a racing heartbeat.\n\n13. Can I stop taking bisoprolol suddenly if I feel fine?\nNo. Stopping abruptly can cause a rebound rise in heart rate, blood pressure, or chest pain. Reduce the dose gradually under medical guidance.\n\n14. Does bisoprolol interact with other blood pressure medicines?\nYes. Combining it with other drugs that lower heart rate or pressure (such as calcium channel blockers) can cause a very low pulse or pressure. Tell your doctor about all your medicines.\n\n15. Is BISOGARD 1.25 available without a prescription?\nNo. Bisoprolol is a Schedule H medicine in India and needs a valid prescription.\n\n16. How long does it take for bisoprolol 1.25mg to start working?\nSome effect on heart rate appears within hours, but the full benefit for blood pressure or heart failure symptoms builds over several weeks of regular use.\n\n17. Can pregnant women take bisoprolol?\nOnly if clearly necessary and prescribed by a doctor, as it may affect the baby's heart rate and growth.", "price": 39.0, "discountamount": 12.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2501, "imageuri": "https://productimages.withfloats.com/actual/6abe4474c205678e0b16a23a.png", "tileimageuri": "https://productimages.withfloats.com/tile/6abe4474c205678e0b16a23a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2026-10-01T11:30:57.88Z", "updatedon": "2026-10-01T11:30:57.88Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//bisoprolol-1-25mg/2501", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Bisogard 1.25", "category": "CARDIOLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }